{
  "@context": "aku-v2",
  "@type": "genetics",
  "@id": "vasc:hht:type2-acvrl1",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:15:00.000Z",
    "updated": "2026-01-07T03:15:00.000Z",
    "contributors": [
      "knowledge-graph-agent"
    ],
    "confidence": 0.92,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-disorders",
    "type": "genetic-syndrome",
    "difficulty": "advanced",
    "importance": "specialized"
  },
  "content": {
    "title": "Hereditary Hemorrhagic Telangiectasia Type 2 (ACVRL1)",
    "description": "HHT Type 2 caused by mutations in the ACVRL1 gene encoding ALK1",
    "key_concepts": [
      {
        "concept": "Genetic Basis",
        "details": "Autosomal dominant mutations in ACVRL1 gene encoding activin receptor-like kinase 1 (ALK1)"
      },
      {
        "concept": "Hepatic AVM Prevalence",
        "details": "Higher prevalence of hepatic AVMs compared to HHT Type 1"
      },
      {
        "concept": "Clinical Features",
        "details": "Later onset of symptoms, mucocutaneous telangiectasias, hepatic vascular malformations"
      },
      {
        "concept": "Pulmonary AVMs",
        "details": "Lower prevalence of pulmonary AVMs (approximately 20-30%) compared to Type 1"
      }
    ],
    "clinical_significance": "HHT Type 2 requires hepatic screening and monitoring for high-output cardiac failure",
    "statement": "Hereditary Hemorrhagic Telangiectasia Type 2 (ACVRL1) is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Genetic-Disorders that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Hereditary Hemorrhagic Telangiectasia Type 2 (ACVRL1) helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Hereditary Hemorrhagic Telangiectasia Type 2 (ACVRL1) include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Hereditary Hemorrhagic Telangiectasia Type 2 (ACVRL1)."
    }
  },
  "relationships": [
    {
      "predicate": "relatedTo",
      "object": "vasc:hht:hepatic-avm"
    }
  ],
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Hereditary Hemorrhagic Telangiectasia Type 2 (ACVRL1). Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}